IPOs

Gamida Cell raises $50M in NASDAQ IPO
BioCentury
Sat, 10/27/18 - 11:57 am
Gamida Cell
IPOs
NASDAQ
cell therapy
Hong Kong IPO delivers $421M to Innovent — fourth listed biotech in six months
Endpoints
Wed, 10/24/18 - 10:12 am
Hong Kong
IPOs
biotech
Innovent Biologics
Si-Bone closes $124m IPO
Mass Device
Mon, 10/22/18 - 10:50 pm
SI-BONE
IPOs
devices
Vapotherm registers $58m IPO
Mass Device
Mon, 10/22/18 - 05:06 pm
Vapotherm
IPOs
devices
Precision Flow
Novartis in constant evolution: new large investment in startup
GoinPharma
Sun, 10/21/18 - 11:31 pm
Gamida Cell
IPOs
Novartis
NiCord
PhaseBio, Osmotica price IPOs well below range
BioCentury
Thu, 10/18/18 - 11:47 pm
PhaseBio
Osmotica Pharmaceuticals
IPOs
Innovent Biologics Plans Hong Kong IPO to Raise $423 Million, Despite Global Downturn
Biopharma Dive
Mon, 10/15/18 - 12:07 pm
IPOs
Innovent Biologics
Hong Kong
BioSpace's List of Q4 2018 Life Sciences IPOs
BioSpace
Sat, 10/13/18 - 10:55 pm
biotech
IPOs
Hoth Therapeutics seeks IPO cash to battle eczema
Fierce Biotech
Fri, 10/12/18 - 10:21 am
Hoth Therapeutics
IPOs
NASDAQ
eczema
Allogene raises $324M in year's largest biotech IPO on NASDAQ
BioCentury
Wed, 10/10/18 - 10:56 pm
Allogene
IPOs
cell therapy
NASDAQ
4 Reasons to Be Wary of This Animal Health IPO
Motley Fool
Tue, 10/9/18 - 04:58 pm
Elanco
IPOs
Eli Lilly
animal health
Axonics Modulation files for $86m IPO
Mass Device
Tue, 10/9/18 - 09:51 am
devices
IPOs
Axonics
neuromodulation
Peninsula biotech coughs up 40 percent of its value on failed clinical trial
Bizjournals.com
Mon, 10/8/18 - 10:53 pm
clinical trials
IPOs
Menlo Therapeutics
serlopitant
Orchard Therapeutics proposes IPO
BioCentury
Fri, 10/5/18 - 09:49 am
Orchard Therapeutics
IPOs
Allogene IPO could be year's largest biotech listing on NASDAQ
BioCentury
Tue, 10/2/18 - 07:45 pm
IPOs
NASDAQ
Allogene
CAR-T
Israel-Based Gamida Cell Files for $69 Million IPO
BioSpace
Mon, 10/1/18 - 07:21 pm
Gamida Cell
IPOs
Israel
NASDAQ
Gritstone raises $100M in upsized IPO
BioCentury
Fri, 09/28/18 - 10:25 am
Gritsone Oncology
IPOs
Nasdaq triple IPO play brings in $345M as the big biotech party rocks on
Endpoints
Thu, 09/27/18 - 11:55 am
NASDAQ
IPOs
Entasis
Urovant Sciences
Arvinas
Sutro BioPharma
Entasis dips in first trading day after $75M IPO
BioCentury
Wed, 09/26/18 - 07:26 pm
IPOs
AstraZeneca
Entasis
PhaseBio details dollars in AstraZeneca deal as it rolls out a plan for $86M-plus IPO
Endpoints
Mon, 09/24/18 - 09:44 am
PhaseBio
IPOs
PB2452
anti-anti-coagulants
AstraZeneca

Pages